Patent Yard Sign in
Canadian application, no grantCanada

Method for treating psoriasis

CA 2435151 A1 · Owner: Moore, Emma E. · Inventors: Moore, Emma E.; Presnell, Scott R.; Madden, Karen L.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for treating psoriasis. An antagonist to IL-17D.beta.9(IL-17D) is administered to treat psoriasis. The antagonist can be an antibody that binds to IL-17D.beta.9 or its receptor or a soluble receptor that binds to IL- 17D.beta.9 or a membrane-spanning protein-5 (MSP-5).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 24, 2002
GrantedNo grant recorded
Term endedJanuary 24, 2022
Patent numberCA 2435151 A1
Classification (IPC)A61K39/39 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 24, 2002Term endedJan 24, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.